市場調查報告書
商品編碼
1067806

數位生物標記的全球市場的洞察,至2028年的預測

Global Digital Biomarker Market Insights, Forecast to 2028

出版日期: | 出版商: QYResearch | 英文 112 Pages | 商品交期: 2-3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

全球數位生物標記的市場規模,2021年是3億8,720萬美金。

該市場,預計從2022年到2028年之間以82.5%的年複合成長率發展,2028年達到223億6,000萬美元。

本報告提供全球數位生物標記市場相關調查,市場規模和預測,各類型、用途、企業、地區的市場分析,市場動態,競爭情形,主要企業的簡介等資訊。

目錄

第1章 報告商務概要

  • 調查範圍
  • 各類型市場分析
    • 市場規模的成長率(2017 VS 2021 VS 2028)
    • 被動式數位生物標記
    • 主動式數位生物標記
  • 各用途市場
    • 市場規模的成長率(2017 VS 2021 VS 2028)
    • 臨床疾病
    • 每天的健康
  • 調查目的
  • 考慮年

第2章 全球成長趨勢

  • 全球市場的展望(2017-2028)
  • 各地區:成長趨勢
  • 市場動態
    • 產業趨勢
    • 市場促進因素
    • 市場課題
    • 市場阻礙因素

第3章 各主要企業:競爭情形

  • 各收益:主要企業
  • 各類型企業:市場佔有率(Tier 1,Tier 2,Tier 3)
  • 對象企業:各收益排行榜
  • 全球市場集中度
  • 主要企業總公司與提供區域
  • 主要企業的產品解決方案和服務
  • 市場進入日
  • 合併和收購,擴張計劃

第4章 各類型:數位生物標記的明細資料

  • 各類型:市場規模成果(2017-2022)
  • 各類型:市場規模預測(2023-2028)

第5章 各用途:數位生物標記的明細資料

  • 各用途:市場規模成果(2017-2022)
  • 各用途:市場規模預測(2023-2028)

第6章 北美

  • 市場規模(2017-2028)
  • 各類型:市場規模
  • 各用途:市場規模
  • 各國:市場規模
    • 市場規模(2017-2022)
    • 市場規模(2023-2028)
    • 美國
    • 加拿大

第7章 歐洲

  • 市場規模(2017-2028)
  • 各類型:市場規模
  • 各用途:市場規模
  • 各國:市場規模
    • 市場規模(2017-2022)
    • 市場規模(2023-2028)
    • 德國
    • 法國
    • 英國
    • 義大利
    • 俄羅斯
    • 北歐各國

第8章 亞太地區

  • 市場規模(2017-2028)
  • 各類型:市場規模
  • 各用途:市場規模
  • 各地區:市場規模
    • 市場規模(2017-2022)
    • 市場規模(2023-2028)
    • 中國
    • 日本
    • 韓國
    • 東南亞
    • 印度
    • 澳洲

第9章 南美

  • 市場規模(2017-2028)
  • 各類型:市場規模
  • 各用途:市場規模
  • 各國:市場規模
    • 市場規模(2017-2022)
    • 市場規模(2023-2028)
    • 墨西哥
    • 巴西

第10章 中東和非洲

  • 市場規模(2017-2028)
  • 各類型:市場規模
  • 各用途:市場規模
  • 各國:市場規模
    • 市場規模(2017-2022)
    • 市場規模(2023-2028)
    • 土耳其
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第11章 主要企業的簡介

  • Philips
  • Johnson &Johnson
  • Pfizer
  • GE Healthcare
  • Novartis
  • Apple
  • Sanofi
  • GlaxoSmithKline
  • Bayer
  • Merck
  • Abbott Laboratories
  • Asahi Kasei
  • Biogen
  • Koneksa Health
  • Roche
  • Huma Therapeutics

第12章 分析師的見解/結論

第13章 附錄

目錄

Digital biomarkers are defined as objective, quantifiable physiological and behavioral data that are collected and measured by means of digital devices such as portables, wearables, implantables, or digestibles. The data collected are typically used to explain, influence, and/or predict health-related outcomes. Digital biomarkers also represent an opportunity to capture clinically meaningful, objective data.

Market Analysis and Insights: Global Digital Biomarker Market

The global Digital Biomarker market size is projected to reach US$ 22360 million by 2028, from US$ 387.2 million in 2021, at a CAGR of 82.5% during 2022-2028.

Philips and Novartis are the top 2 companies in global digital biomarker market and account for over 15% of total market share. Geographically speaking, Europe holds about 45% of global market share, followed by North America with about 35% share. In terms of type, passive digital biomarker segment holds an important share of about 65%. In terms of application, clinical disease segment accounts for about 80% of the total share.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Digital Biomarker market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Digital Biomarker market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Digital Biomarker market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Digital Biomarker market.

Global Digital Biomarker Scope and Market Size

Digital Biomarker market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Digital Biomarker market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

  • Passive Digital Biomarker
  • Active Digital Biomarker

Segment by Application

  • Clinical Disease
  • Daily Health

By Company

  • Philips
  • Johnson & Johnson
  • Pfizer
  • GE Healthcare
  • Novartis
  • Apple
  • Sanofi
  • GlaxoSmithKline
  • Bayer
  • Merck
  • Abbott Laboratories
  • Asahi Kasei
  • Biogen
  • Koneksa Health
  • Roche
  • Huma Therapeutics

By Region

  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
    • Nordic Countries
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

TABLE OF CONTENTS

1 Report Business Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Digital Biomarker Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
    • 1.2.2 Passive Digital Biomarker
    • 1.2.3 Active Digital Biomarker
  • 1.3 Market by Application
    • 1.3.1 Global Digital Biomarker Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
    • 1.3.2 Clinical Disease
    • 1.3.3 Daily Health
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Digital Biomarker Market Perspective (2017-2028)
  • 2.2 Digital Biomarker Growth Trends by Region
    • 2.2.1 Digital Biomarker Market Size by Region: 2017 VS 2021 VS 2028
    • 2.2.2 Digital Biomarker Historic Market Size by Region (2017-2022)
    • 2.2.3 Digital Biomarker Forecasted Market Size by Region (2023-2028)
  • 2.3 Digital Biomarker Market Dynamics
    • 2.3.1 Digital Biomarker Industry Trends
    • 2.3.2 Digital Biomarker Market Drivers
    • 2.3.3 Digital Biomarker Market Challenges
    • 2.3.4 Digital Biomarker Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Digital Biomarker Players by Revenue
    • 3.1.1 Global Top Digital Biomarker Players by Revenue (2017-2022)
    • 3.1.2 Global Digital Biomarker Revenue Market Share by Players (2017-2022)
  • 3.2 Global Digital Biomarker Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Players Covered: Ranking by Digital Biomarker Revenue
  • 3.4 Global Digital Biomarker Market Concentration Ratio
    • 3.4.1 Global Digital Biomarker Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Digital Biomarker Revenue in 2021
  • 3.5 Digital Biomarker Key Players Head office and Area Served
  • 3.6 Key Players Digital Biomarker Product Solution and Service
  • 3.7 Date of Enter into Digital Biomarker Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Digital Biomarker Breakdown Data by Type

  • 4.1 Global Digital Biomarker Historic Market Size by Type (2017-2022)
  • 4.2 Global Digital Biomarker Forecasted Market Size by Type (2023-2028)

5 Digital Biomarker Breakdown Data by Application

  • 5.1 Global Digital Biomarker Historic Market Size by Application (2017-2022)
  • 5.2 Global Digital Biomarker Forecasted Market Size by Application (2023-2028)

6 North America

  • 6.1 North America Digital Biomarker Market Size (2017-2028)
  • 6.2 North America Digital Biomarker Market Size by Type
    • 6.2.1 North America Digital Biomarker Market Size by Type (2017-2022)
    • 6.2.2 North America Digital Biomarker Market Size by Type (2023-2028)
    • 6.2.3 North America Digital Biomarker Market Share by Type (2017-2028)
  • 6.3 North America Digital Biomarker Market Size by Application
    • 6.3.1 North America Digital Biomarker Market Size by Application (2017-2022)
    • 6.3.2 North America Digital Biomarker Market Size by Application (2023-2028)
    • 6.3.3 North America Digital Biomarker Market Share by Application (2017-2028)
  • 6.4 North America Digital Biomarker Market Size by Country
    • 6.4.1 North America Digital Biomarker Market Size by Country (2017-2022)
    • 6.4.2 North America Digital Biomarker Market Size by Country (2023-2028)
    • 6.4.3 United States
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Digital Biomarker Market Size (2017-2028)
  • 7.2 Europe Digital Biomarker Market Size by Type
    • 7.2.1 Europe Digital Biomarker Market Size by Type (2017-2022)
    • 7.2.2 Europe Digital Biomarker Market Size by Type (2023-2028)
    • 7.2.3 Europe Digital Biomarker Market Share by Type (2017-2028)
  • 7.3 Europe Digital Biomarker Market Size by Application
    • 7.3.1 Europe Digital Biomarker Market Size by Application (2017-2022)
    • 7.3.2 Europe Digital Biomarker Market Size by Application (2023-2028)
    • 7.3.3 Europe Digital Biomarker Market Share by Application (2017-2028)
  • 7.4 Europe Digital Biomarker Market Size by Country
    • 7.4.1 Europe Digital Biomarker Market Size by Country (2017-2022)
    • 7.4.2 Europe Digital Biomarker Market Size by Country (2023-2028)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic Countries

8 Asia-Pacific

  • 8.1 Asia-Pacific Digital Biomarker Market Size (2017-2028)
  • 8.2 Asia-Pacific Digital Biomarker Market Size by Type
    • 8.2.1 Asia-Pacific Digital Biomarker Market Size by Type (2017-2022)
    • 8.2.2 Asia-Pacific Digital Biomarker Market Size by Type (2023-2028)
    • 8.2.3 Asia-Pacific Digital Biomarker Market Share by Type (2017-2028)
  • 8.3 Asia-Pacific Digital Biomarker Market Size by Application
    • 8.3.1 Asia-Pacific Digital Biomarker Market Size by Application (2017-2022)
    • 8.3.2 Asia-Pacific Digital Biomarker Market Size by Application (2023-2028)
    • 8.3.3 Asia-Pacific Digital Biomarker Market Share by Application (2017-2028)
  • 8.4 Asia-Pacific Digital Biomarker Market Size by Region
    • 8.4.1 Asia-Pacific Digital Biomarker Market Size by Region (2017-2022)
    • 8.4.2 Asia-Pacific Digital Biomarker Market Size by Region (2023-2028)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Digital Biomarker Market Size (2017-2028)
  • 9.2 Latin America Digital Biomarker Market Size by Type
    • 9.2.1 Latin America Digital Biomarker Market Size by Type (2017-2022)
    • 9.2.2 Latin America Digital Biomarker Market Size by Type (2023-2028)
    • 9.2.3 Latin America Digital Biomarker Market Share by Type (2017-2028)
  • 9.3 Latin America Digital Biomarker Market Size by Application
    • 9.3.1 Latin America Digital Biomarker Market Size by Application (2017-2022)
    • 9.3.2 Latin America Digital Biomarker Market Size by Application (2023-2028)
    • 9.3.3 Latin America Digital Biomarker Market Share by Application (2017-2028)
  • 9.4 Latin America Digital Biomarker Market Size by Country
    • 9.4.1 Latin America Digital Biomarker Market Size by Country (2017-2022)
    • 9.4.2 Latin America Digital Biomarker Market Size by Country (2023-2028)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Digital Biomarker Market Size (2017-2028)
  • 10.2 Middle East & Africa Digital Biomarker Market Size by Type
    • 10.2.1 Middle East & Africa Digital Biomarker Market Size by Type (2017-2022)
    • 10.2.2 Middle East & Africa Digital Biomarker Market Size by Type (2023-2028)
    • 10.2.3 Middle East & Africa Digital Biomarker Market Share by Type (2017-2028)
  • 10.3 Middle East & Africa Digital Biomarker Market Size by Application
    • 10.3.1 Middle East & Africa Digital Biomarker Market Size by Application (2017-2022)
    • 10.3.2 Middle East & Africa Digital Biomarker Market Size by Application (2023-2028)
    • 10.3.3 Middle East & Africa Digital Biomarker Market Share by Application (2017-2028)
  • 10.4 Middle East & Africa Digital Biomarker Market Size by Country
    • 10.4.1 Middle East & Africa Digital Biomarker Market Size by Country (2017-2022)
    • 10.4.2 Middle East & Africa Digital Biomarker Market Size by Country (2023-2028)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Philips
    • 11.1.1 Philips Company Details
    • 11.1.2 Philips Business Overview
    • 11.1.3 Philips Digital Biomarker Introduction
    • 11.1.4 Philips Revenue in Digital Biomarker Business (2017-2022)
    • 11.1.5 Philips Recent Developments
  • 11.2 Johnson & Johnson
    • 11.2.1 Johnson & Johnson Company Details
    • 11.2.2 Johnson & Johnson Business Overview
    • 11.2.3 Johnson & Johnson Digital Biomarker Introduction
    • 11.2.4 Johnson & Johnson Revenue in Digital Biomarker Business (2017-2022)
    • 11.2.5 Johnson & Johnson Recent Developments
  • 11.3 Pfizer
    • 11.3.1 Pfizer Company Details
    • 11.3.2 Pfizer Business Overview
    • 11.3.3 Pfizer Digital Biomarker Introduction
    • 11.3.4 Pfizer Revenue in Digital Biomarker Business (2017-2022)
    • 11.3.5 Pfizer Recent Developments
  • 11.4 GE Healthcare
    • 11.4.1 GE Healthcare Company Details
    • 11.4.2 GE Healthcare Business Overview
    • 11.4.3 GE Healthcare Digital Biomarker Introduction
    • 11.4.4 GE Healthcare Revenue in Digital Biomarker Business (2017-2022)
    • 11.4.5 GE Healthcare Recent Developments
  • 11.5 Novartis
    • 11.5.1 Novartis Company Details
    • 11.5.2 Novartis Business Overview
    • 11.5.3 Novartis Digital Biomarker Introduction
    • 11.5.4 Novartis Revenue in Digital Biomarker Business (2017-2022)
    • 11.5.5 Novartis Recent Developments
  • 11.6 Apple
    • 11.6.1 Apple Company Details
    • 11.6.2 Apple Business Overview
    • 11.6.3 Apple Digital Biomarker Introduction
    • 11.6.4 Apple Revenue in Digital Biomarker Business (2017-2022)
    • 11.6.5 Apple Recent Developments
  • 11.7 Sanofi
    • 11.7.1 Sanofi Company Details
    • 11.7.2 Sanofi Business Overview
    • 11.7.3 Sanofi Digital Biomarker Introduction
    • 11.7.4 Sanofi Revenue in Digital Biomarker Business (2017-2022)
    • 11.7.5 Sanofi Recent Developments
  • 11.8 GlaxoSmithKline
    • 11.8.1 GlaxoSmithKline Company Details
    • 11.8.2 GlaxoSmithKline Business Overview
    • 11.8.3 GlaxoSmithKline Digital Biomarker Introduction
    • 11.8.4 GlaxoSmithKline Revenue in Digital Biomarker Business (2017-2022)
    • 11.8.5 GlaxoSmithKline Recent Developments
  • 11.9 Bayer
    • 11.9.1 Bayer Company Details
    • 11.9.2 Bayer Business Overview
    • 11.9.3 Bayer Digital Biomarker Introduction
    • 11.9.4 Bayer Revenue in Digital Biomarker Business (2017-2022)
    • 11.9.5 Bayer Recent Developments
  • 11.10 Merck
    • 11.10.1 Merck Company Details
    • 11.10.2 Merck Business Overview
    • 11.10.3 Merck Digital Biomarker Introduction
    • 11.10.4 Merck Revenue in Digital Biomarker Business (2017-2022)
    • 11.10.5 Merck Recent Developments
  • 11.11 Abbott Laboratories
    • 11.11.1 Abbott Laboratories Company Details
    • 11.11.2 Abbott Laboratories Business Overview
    • 11.11.3 Abbott Laboratories Digital Biomarker Introduction
    • 11.11.4 Abbott Laboratories Revenue in Digital Biomarker Business (2017-2022)
    • 11.11.5 Abbott Laboratories Recent Developments
  • 11.12 Asahi Kasei
    • 11.12.1 Asahi Kasei Company Details
    • 11.12.2 Asahi Kasei Business Overview
    • 11.12.3 Asahi Kasei Digital Biomarker Introduction
    • 11.12.4 Asahi Kasei Revenue in Digital Biomarker Business (2017-2022)
    • 11.12.5 Asahi Kasei Recent Developments
  • 11.13 Biogen
    • 11.13.1 Biogen Company Details
    • 11.13.2 Biogen Business Overview
    • 11.13.3 Biogen Digital Biomarker Introduction
    • 11.13.4 Biogen Revenue in Digital Biomarker Business (2017-2022)
    • 11.13.5 Biogen Recent Developments
  • 11.14 Koneksa Health
    • 11.14.1 Koneksa Health Company Details
    • 11.14.2 Koneksa Health Business Overview
    • 11.14.3 Koneksa Health Digital Biomarker Introduction
    • 11.14.4 Koneksa Health Revenue in Digital Biomarker Business (2017-2022)
    • 11.14.5 Koneksa Health Recent Developments
  • 11.15 Roche
    • 11.15.1 Roche Company Details
    • 11.15.2 Roche Business Overview
    • 11.15.3 Roche Digital Biomarker Introduction
    • 11.15.4 Roche Revenue in Digital Biomarker Business (2017-2022)
    • 11.15.5 Roche Recent Developments
  • 11.16 Huma Therapeutics
    • 11.16.1 Huma Therapeutics Company Details
    • 11.16.2 Huma Therapeutics Business Overview
    • 11.16.3 Huma Therapeutics Digital Biomarker Introduction
    • 11.16.4 Huma Therapeutics Revenue in Digital Biomarker Business (2017-2022)
    • 11.16.5 Huma Therapeutics Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Author Details
  • 13.3 Disclaimer

LIST OF TABLES

List of Tables

  • Table 1. Global Digital Biomarker Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
  • Table 2. Key Players of Passive Digital Biomarker
  • Table 3. Key Players of Active Digital Biomarker
  • Table 4. Global Digital Biomarker Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
  • Table 5. Global Digital Biomarker Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
  • Table 6. Global Digital Biomarker Market Size by Region (2017-2022) & (US$ Million)
  • Table 7. Global Digital Biomarker Market Share by Region (2017-2022)
  • Table 8. Global Digital Biomarker Forecasted Market Size by Region (2023-2028) & (US$ Million)
  • Table 9. Global Digital Biomarker Market Share by Region (2023-2028)
  • Table 10. Digital Biomarker Market Trends
  • Table 11. Digital Biomarker Market Drivers
  • Table 12. Digital Biomarker Market Challenges
  • Table 13. Digital Biomarker Market Restraints
  • Table 14. Global Digital Biomarker Revenue by Players (2017-2022) & (US$ Million)
  • Table 15. Global Digital Biomarker Revenue Share by Players (2017-2022)
  • Table 16. Global Top Digital Biomarker by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Digital Biomarker as of 2021)
  • Table 17. Ranking of Global Top Digital Biomarker Companies by Revenue (US$ Million) in 2021
  • Table 18. Global 5 Largest Players Market Share by Digital Biomarker Revenue (CR5 and HHI) & (2017-2022)
  • Table 19. Key Players Headquarters and Area Served
  • Table 20. Key Players Digital Biomarker Product Solution and Service
  • Table 21. Date of Enter into Digital Biomarker Market
  • Table 22. Mergers & Acquisitions, Expansion Plans
  • Table 23. Global Digital Biomarker Market Size by Type (2017-2022) & (US$ Million)
  • Table 24. Global Digital Biomarker Revenue Market Share by Type (2017-2022)
  • Table 25. Global Digital Biomarker Forecasted Market Size by Type (2023-2028) & (US$ Million)
  • Table 26. Global Digital Biomarker Revenue Market Share by Type (2023-2028)
  • Table 27. Global Digital Biomarker Market Size by Application (2017-2022) & (US$ Million)
  • Table 28. Global Digital Biomarker Revenue Share by Application (2017-2022)
  • Table 29. Global Digital Biomarker Forecasted Market Size by Application (2023-2028) & (US$ Million)
  • Table 30. Global Digital Biomarker Revenue Share by Application (2023-2028)
  • Table 31. North America Digital Biomarker Market Size by Type (2017-2022) & (US$ Million)
  • Table 32. North America Digital Biomarker Market Size by Type (2023-2028) & (US$ Million)
  • Table 33. North America Digital Biomarker Market Size by Application (2017-2022) & (US$ Million)
  • Table 34. North America Digital Biomarker Market Size by Application (2023-2028) & (US$ Million)
  • Table 35. North America Digital Biomarker Market Size by Country (2017-2022) & (US$ Million)
  • Table 36. North America Digital Biomarker Market Size by Country (2023-2028) & (US$ Million)
  • Table 37. Europe Digital Biomarker Market Size by Type (2017-2022) & (US$ Million)
  • Table 38. Europe Digital Biomarker Market Size by Type (2023-2028) & (US$ Million)
  • Table 39. Europe Digital Biomarker Market Size by Application (2017-2022) & (US$ Million)
  • Table 40. Europe Digital Biomarker Market Size by Application (2023-2028) & (US$ Million)
  • Table 41. Europe Digital Biomarker Market Size by Country (2017-2022) & (US$ Million)
  • Table 42. Europe Digital Biomarker Market Size by Country (2023-2028) & (US$ Million)
  • Table 43. Asia Pacific Digital Biomarker Market Size by Type (2017-2022) & (US$ Million)
  • Table 44. Asia Pacific Digital Biomarker Market Size by Type (2023-2028) & (US$ Million)
  • Table 45. Asia Pacific Digital Biomarker Market Size by Application (2017-2022) & (US$ Million)
  • Table 46. Asia Pacific Digital Biomarker Market Size by Application (2023-2028) & (US$ Million)
  • Table 47. Asia Pacific Digital Biomarker Market Size by Region (2017-2022) & (US$ Million)
  • Table 48. Asia Pacific Digital Biomarker Market Size by Region (2023-2028) & (US$ Million)
  • Table 49. Latin America Digital Biomarker Market Size by Type (2017-2022) & (US$ Million)
  • Table 50. Latin America Digital Biomarker Market Size by Type (2023-2028) & (US$ Million)
  • Table 51. Latin America Digital Biomarker Market Size by Application (2017-2022) & (US$ Million)
  • Table 52. Latin America Digital Biomarker Market Size by Application (2023-2028) & (US$ Million)
  • Table 53. Latin America Digital Biomarker Market Size by Country (2017-2022) & (US$ Million)
  • Table 54. Latin America Digital Biomarker Market Size by Country (2023-2028) & (US$ Million)
  • Table 55. Middle East and Africa Digital Biomarker Market Size by Type (2017-2022) & (US$ Million)
  • Table 56. Middle East and Africa Digital Biomarker Market Size by Type (2023-2028) & (US$ Million)
  • Table 57. Middle East and Africa Digital Biomarker Market Size by Application (2017-2022) & (US$ Million)
  • Table 58. Middle East and Africa Digital Biomarker Market Size by Application (2023-2028) & (US$ Million)
  • Table 59. Middle East and Africa Digital Biomarker Market Size by Country (2017-2022) & (US$ Million)
  • Table 60. Middle East and Africa Digital Biomarker Market Size by Country (2023-2028) & (US$ Million)
  • Table 61. Philips Company Details
  • Table 62. Philips Business Overview
  • Table 63. Philips Digital Biomarker Product
  • Table 64. Philips Revenue in Digital Biomarker Business (2017-2022) & (US$ Million)
  • Table 65. Philips Recent Developments
  • Table 66. Johnson & Johnson Company Details
  • Table 67. Johnson & Johnson Business Overview
  • Table 68. Johnson & Johnson Digital Biomarker Product
  • Table 69. Johnson & Johnson Revenue in Digital Biomarker Business (2017-2022) & (US$ Million)
  • Table 70. Johnson & Johnson Recent Developments
  • Table 71. Pfizer Company Details
  • Table 72. Pfizer Business Overview
  • Table 73. Pfizer Digital Biomarker Product
  • Table 74. Pfizer Revenue in Digital Biomarker Business (2017-2022) & (US$ Million)
  • Table 75. Pfizer Recent Developments
  • Table 76. GE Healthcare Company Details
  • Table 77. GE Healthcare Business Overview
  • Table 78. GE Healthcare Digital Biomarker Product
  • Table 79. GE Healthcare Revenue in Digital Biomarker Business (2017-2022) & (US$ Million)
  • Table 80. GE Healthcare Recent Developments
  • Table 81. Novartis Company Details
  • Table 82. Novartis Business Overview
  • Table 83. Novartis Digital Biomarker Product
  • Table 84. Novartis Revenue in Digital Biomarker Business (2017-2022) & (US$ Million)
  • Table 85. Novartis Recent Developments
  • Table 86. Apple Company Details
  • Table 87. Apple Business Overview
  • Table 88. Apple Digital Biomarker Product
  • Table 89. Apple Revenue in Digital Biomarker Business (2017-2022) & (US$ Million)
  • Table 90. Apple Recent Developments
  • Table 91. Sanofi Company Details
  • Table 92. Sanofi Business Overview
  • Table 93. Sanofi Digital Biomarker Product
  • Table 94. Sanofi Revenue in Digital Biomarker Business (2017-2022) & (US$ Million)
  • Table 95. Sanofi Recent Developments
  • Table 96. GlaxoSmithKline Company Details
  • Table 97. GlaxoSmithKline Business Overview
  • Table 98. GlaxoSmithKline Digital Biomarker Product
  • Table 99. GlaxoSmithKline Revenue in Digital Biomarker Business (2017-2022) & (US$ Million)
  • Table 100. GlaxoSmithKline Recent Developments
  • Table 101. Bayer Company Details
  • Table 102. Bayer Business Overview
  • Table 103. Bayer Digital Biomarker Product
  • Table 104. Bayer Revenue in Digital Biomarker Business (2017-2022) & (US$ Million)
  • Table 105. Bayer Recent Developments
  • Table 106. Merck Company Details
  • Table 107. Merck Business Overview
  • Table 108. Merck Digital Biomarker Product
  • Table 109. Merck Revenue in Digital Biomarker Business (2017-2022) & (US$ Million)
  • Table 110. Merck Recent Developments
  • Table 111. Abbott Laboratories Company Details
  • Table 112. Abbott Laboratories Business Overview
  • Table 113. Abbott Laboratories Digital Biomarker Product
  • Table 114. Abbott Laboratories Revenue in Digital Biomarker Business (2017-2022) & (US$ Million)
  • Table 115. Abbott Laboratories Recent Developments
  • Table 116. Asahi Kasei Company Details
  • Table 117. Asahi Kasei Business Overview
  • Table 118. Asahi Kasei Digital Biomarker Product
  • Table 119. Asahi Kasei Revenue in Digital Biomarker Business (2017-2022) & (US$ Million)
  • Table 120. Asahi Kasei Recent Developments
  • Table 121. Biogen Company Details
  • Table 122. Biogen Business Overview
  • Table 123. Biogen Digital Biomarker Product
  • Table 124. Biogen Revenue in Digital Biomarker Business (2017-2022) & (US$ Million)
  • Table 125. Biogen Recent Developments
  • Table 126. Koneksa Health Company Details
  • Table 127. Koneksa Health Business Overview
  • Table 128. Koneksa Health Digital Biomarker Product
  • Table 129. Koneksa Health Revenue in Digital Biomarker Business (2017-2022) & (US$ Million)
  • Table 130. Koneksa Health Recent Developments
  • Table 131. Roche Company Details
  • Table 132. Roche Business Overview
  • Table 133. Roche Digital Biomarker Product
  • Table 134. Roche Revenue in Digital Biomarker Business (2017-2022) & (US$ Million)
  • Table 135. Roche Recent Developments
  • Table 136. Huma Therapeutics Company Details
  • Table 137. Huma Therapeutics Business Overview
  • Table 138. Huma Therapeutics Digital Biomarker Product
  • Table 139. Huma Therapeutics Revenue in Digital Biomarker Business (2017-2022) & (US$ Million)
  • Table 140. Huma Therapeutics Recent Developments
  • Table 141. Research Programs/Design for This Report
  • Table 142. Key Data Information from Secondary Sources
  • Table 143. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global Digital Biomarker Market Share by Type: 2021 VS 2028
  • Figure 2. Passive Digital Biomarker Features
  • Figure 3. Active Digital Biomarker Features
  • Figure 4. Global Digital Biomarker Market Share by Application: 2021 VS 2028
  • Figure 5. Clinical Disease Case Studies
  • Figure 6. Daily Health Case Studies
  • Figure 7. Digital Biomarker Report Years Considered
  • Figure 8. Global Digital Biomarker Market Size (US$ Million), Year-over-Year: 2017-2028
  • Figure 9. Global Digital Biomarker Market Size, (US$ Million), 2017 VS 2021 VS 2028
  • Figure 10. Global Digital Biomarker Market Share by Region: 2021 VS 2028
  • Figure 11. Global Digital Biomarker Market Share by Players in 2021
  • Figure 12. Global Top Digital Biomarker Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Digital Biomarker as of 2021)
  • Figure 13. The Top 10 and 5 Players Market Share by Digital Biomarker Revenue in 2021
  • Figure 14. North America Digital Biomarker Market Size YoY (2017-2028) & (US$ Million)
  • Figure 15. North America Digital Biomarker Market Size Market Share by Type (2017-2028)
  • Figure 16. North America Digital Biomarker Market Size Market Share by Application (2017-2028)
  • Figure 17. North America Digital Biomarker Market Size Share by Country (2017-2028)
  • Figure 18. United States Digital Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 19. Canada Digital Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 20. Europe Digital Biomarker Market Size YoY (2017-2028) & (US$ Million)
  • Figure 21. Europe Digital Biomarker Market Size Market Share by Type (2017-2028)
  • Figure 22. Europe Digital Biomarker Market Size Market Share by Application (2017-2028)
  • Figure 23. Europe Digital Biomarker Market Size Share by Country (2017-2028)
  • Figure 24. Germany Digital Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 25. France Digital Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 26. U.K. Digital Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 27. Italy Digital Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 28. Russia Digital Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 29. Nordic Countries Digital Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 30. Asia-Pacific Digital Biomarker Market Size YoY (2017-2028) & (US$ Million)
  • Figure 31. Asia Pacific Digital Biomarker Market Size Market Share by Type (2017-2028)
  • Figure 32. Asia Pacific Digital Biomarker Market Size Market Share by Application (2017-2028)
  • Figure 33. Asia Pacific Digital Biomarker Market Size Share by Region (2017-2028)
  • Figure 34. China Digital Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 35. Japan Digital Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 36. South Korea Digital Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 37. Southeast Asia Digital Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 38. India Digital Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 39. Australia Digital Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

  • Figure 40. Latin America Digital Biomarker Market Size YoY (2017-2028) & (US$ Million)
  • Figure 41. Latin America Digital Biomarker Market Size Market Share by Type (2017-2028)
  • Figure 42. Latin America Digital Biomarker Market Size Market Share by Application (2017-2028)
  • Figure 43. Latin America Digital Biomarker Market Size Share by Country (2017-2028)
  • Figure 44. Mexico Digital Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 45. Brazil Digital Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 46. Middle East & Africa Digital Biomarker Market Size YoY (2017-2028) & (US$ Million)
  • Figure 47. Middle East and Africa Digital Biomarker Market Size Market Share by Type (2017-2028)
  • Figure 48. Middle East and Africa Digital Biomarker Market Size Market Share by Application (2017-2028)
  • Figure 49. Middle East and Africa Digital Biomarker Market Size Share by Country (2017-2028)
  • Figure 50. Turkey Digital Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 51. Saudi Arabia Digital Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 52. UAE Digital Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 53. Philips Revenue Growth Rate in Digital Biomarker Business (2017-2022)
  • Figure 54. Johnson & Johnson Revenue Growth Rate in Digital Biomarker Business (2017-2022)
  • Figure 55. Pfizer Revenue Growth Rate in Digital Biomarker Business (2017-2022)
  • Figure 56. GE Healthcare Revenue Growth Rate in Digital Biomarker Business (2017-2022)
  • Figure 57. Novartis Revenue Growth Rate in Digital Biomarker Business (2017-2022)
  • Figure 58. Apple Revenue Growth Rate in Digital Biomarker Business (2017-2022)
  • Figure 59. Sanofi Revenue Growth Rate in Digital Biomarker Business (2017-2022)
  • Figure 60. GlaxoSmithKline Revenue Growth Rate in Digital Biomarker Business (2017-2022)
  • Figure 61. Bayer Revenue Growth Rate in Digital Biomarker Business (2017-2022)
  • Figure 62. Merck Revenue Growth Rate in Digital Biomarker Business (2017-2022)
  • Figure 63. Abbott Laboratories Revenue Growth Rate in Digital Biomarker Business (2017-2022)
  • Figure 64. Asahi Kasei Revenue Growth Rate in Digital Biomarker Business (2017-2022)
  • Figure 65. Biogen Revenue Growth Rate in Digital Biomarker Business (2017-2022)
  • Figure 66. Koneksa Health Revenue Growth Rate in Digital Biomarker Business (2017-2022)
  • Figure 67. Roche Revenue Growth Rate in Digital Biomarker Business (2017-2022)
  • Figure 68. Huma Therapeutics Revenue Growth Rate in Digital Biomarker Business (2017-2022)
  • Figure 69. Bottom-up and Top-down Approaches for This Report
  • Figure 70. Data Triangulation
  • Figure 71. Key Executives Interviewed